Roberts Phil Noland 4
4 · Immunome Inc. · Filed Dec 15, 2023
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Roberts Phil Noland
Chief Technology Officer
Transactions
- Award
Stock option (right to buy)
2023-12-13+275,000→ 275,000 totalExercise: $7.34Exp: 2033-12-12→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on December 8, 2024, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.